ArticleAIDS and behavior2026
The Role of PrEP Initiation on Depression Severity, HIV-Related Anxiety, HIV Stigma, and PrEP Stigma Among Sexual Minority Men in Singapore: Findings from a Prospective Cohort and Longitudinal Mixed-Methods Study.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This longitudinal concurrent mixed-methods study examined the impact of initiating HIV pre-exposure prophylaxis (PrEP) on depression severity and HIV- and PrEP-related stigma among gay, bisexual, and other men who have sex with men (GBMSM) in Singapore. A cohort of 53 HIV-negative, GBMSM was followed over 12 months, utilizing repeated quantitative assessments and in-depth qualitative interviews to explore psychosocial outcomes and lived experiences. Quantitative analyses revealed significant reductions in depressive symptoms (adjusted coefficient = -1.55; 95% CI: -2.81, -0.29), HIV-related stigma (-2.26; 95% CI: -4.20, -0.32), and PrEP-related stigma (-2.08; 95% CI: -3.35, -0.81), with the most pronounced improvements observed at the 12-month follow-up compared to baseline and 6-month assessments. Qualitative findings highlighted PrEP's role in alleviating HIV transmission anxiety, enhancing sexual confidence, and fostering a greater sense of agency in participants' health management. Although anxiety was not directly quantified, participants' narratives supported its relief as a psychological benefit of PrEP. Nevertheless, external stigma, particularly the perception of PrEP users as promiscuous persisted, representing a substantial barrier to uptake and adherence. While some participants expressed concerns about risk compensation behaviours, such as reduced condom use, these apprehensions were not corroborated by longitudinal behavioural data. Importantly, PrEP initiation contributed to destigmatization of individuals living with HIV, as participants reported a shift toward greater empathy and openness in their sexual and social relationships. These findings underscore PrEP's dual utility as both a biomedical intervention and a psychological support mechanism. To maximize its public health impact, targeted educational campaigns and culturally tailored stigma reduction strategies, such as, (1) public education to dispel myths about PrEP users, (2) integration of PrEP counselling into primary care and sexual health services, (3) training for healthcare providers on LGBTQ + affirming practices, and (4) financial subsidies to improve affordability. These efforts are critical for promoting PrEP uptake and adherence in Singapore and similar sociocultural settings. This study highlights the multifaceted benefits of PrEP, advocating for its prioritization within comprehensive HIV prevention strategies in the region.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.